Diffuse Lung Disease and Lung Transplant Network
-
Positive results from TETON-1 trial introduce potential new therapy for IPF
Positive results from the TETON trials and expanding treatment options are encouraging for pulmonologists who are used to working with a limited tool kit for slowing disease progression in their patients with IPF.
-
Pulmonary rehabilitation in ILD and PH: Expanding access beyond the center
Pulmonary rehabilitation remains one of the most effective interventions available for chronic respiratory disease. The research has shown a need for structured long-term maintenance programs for patients with ILD and PH.
-
When oil infrastructure burns: What pulmonary clinicians should know
Recent conflict in the Middle East sheds light on oil fires as respiratory exposure events. Pulmonary clinicians need to be prepared to treat both acute and chronic symptoms from these exposures.
-
Airway complications post-lung transplant: Risk factors, outcomes, and interventions
Early detection and phenotype-driven bronchoscopic management are key to improving outcomes in patients with airway complications after undergoing lung transplantation.
-
New statement proposes updated ILD classification, introduces new terminology
A new consensus statement from the American Thoracic Society and the European Respiratory Journal introduces ILD terminology such as bronchiolocentric interstitial pneumonia and alveolar macrophage pneumonia.
-
Closing the gap in pulmonary rehabilitation
If pulmonary rehabilitation in the United States is going to meet the scale of need in coming years, it must grow consistently, equitably, and sustainably.
-
The respiratory toll of traffic pollution in obstructive lung disease and ILD
Traffic-related air pollution reduces lung function and worsens cases of COPD and ILD. Pulmonologists should assess patient exposure and advise on mitigation strategies.
-
Current standards in donor lung procurement and preservation
Review the American Association for Thoracic Surgery’s expert consensus guidelines for improving standardization in key areas of lung acquisition.
-
Update on the evaluation and management of interstitial lung abnormalities
New guidelines from ATS outline the screening and follow-up procedures for interstitial lung abnormalities as well as define who is at higher risk for progressing to ILD.
-
GOLDen handcuffs: Beyond spirometry in COPD
When it comes to diagnosing COPD, clinicians must look beyond spirometry and physiology to see a patient fully.
